Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Georgi, Shukarev"'
Autor:
Anna Lisa Ong-Lim, Georgi Shukarev, Mitzi Trinidad-Aseron, Delia Caparas-Yu, Astrid Greijer, Michel Duchene, Gert Scheper, Vitalija van Paassen, Mathieu Le Gars, Conor P. Cahill, Hanneke Schuitemaker, Macaya Douoguih, Jeanne-Marie Jacquet
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
An inactivated poliovirus vaccine candidate using Sabin strains (sIPV) grown on the PER.C6® cell line was assessed in infants after demonstrated immunogenicity and safety in adults. The study recruited 300 infants who were randomized (1:1:1:1) to re
Externí odkaz:
https://doaj.org/article/e15b3df185804c61b1c2049c272a25ed
Autor:
Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor Cahill, Richard de Rooij, Martin Struijs, Hester van Zeeburg, Jeanne-Marie Jacquet
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1366-1373 (2021)
This first-in-human study (NCT03032588), conducted in Belgium, evaluated a new inactivated poliovirus vaccines (IPV) candidate based on Sabin poliovirus strains grown on the high-yield PER.C6® cell line. Healthy adults (N = 32) were randomized (1:1)
Externí odkaz:
https://doaj.org/article/8d9a181505c642feaf0a71a258804c4c
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 2, Pp 266-270 (2017)
The consequences of the 2013–16 Ebola Zaire virus disease epidemic in West Africa were grave. The economies, healthcare systems and communities of Guinea, Sierra Leone and Liberia were devastated by over 18 months of active Ebola virus transmission
Externí odkaz:
https://doaj.org/article/40c64edefea643de830eb816994756fa
Autor:
Hester van Zeeburg, Conor Cahill, Jeanne-Marie Jacquet, Richard de Rooij, Martin Struijs, Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
HUMAN VACCINES & IMMUNOTHERAPEUTICS
article-version (VoR) Version of Record
HUMAN VACCINES & IMMUNOTHERAPEUTICS
This first-in-human study (NCT03032588), conducted in Belgium, evaluated a new inactivated poliovirus vaccines (IPV) candidate based on Sabin poliovirus strains grown on the high-yield PER.C6 (R) cell line. Healthy adults (N = 32) were randomized (1:
Publikováno v:
Human Vaccines & Immunotherapeutics
The consequences of the 2013–16 Ebola Zaire virus disease epidemic in West Africa were grave. The economies, healthcare systems and communities of Guinea, Sierra Leone and Liberia were devastated by over 18 months of active Ebola virus transmission